Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia

Abstract Inflammation in chronic kidney disease (CKD) is mostly due to activation of the innate immune system, in which Interleukin-1 (IL-1) is a key player. Anemia of CKD may also be due to erythropoietin (EPO) resistance, clinically associated with inflammation. IL-1 receptor antagonist knockout (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Inbar Bandach, Yael Segev, Daniel Landau
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0767ab32067442dda336ee71243999d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!